-+ 0.00%
-+ 0.00%
-+ 0.00%

INNOCAN PHARMA ANNOUNCES SECOND QUARTER FISCAL YEAR 2026 RESULTS, WITH REVENUE OF US$5.25M (CAD 7.3M)

Reuters·08/31/2026 20:01:00

Please log in to view news